Positron emission tomography imaging of colorectal cancer with 89Zr-labeled huA33 antibody

被引：0
|
作者：
Zeglis, Brian M. [1 ]
Mohindra, Priya [1 ]
Larson, Steven M. [1 ]
Lewis, Jason S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 243卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
68-NUCL
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Functional Imaging of Colorectal Cancer: Positron Emission Tomography, Magnetic Resonance Imaging, and Computed Tomography
    Kapse, Nikhil
    Goh, Vicky
    CLINICAL COLORECTAL CANCER, 2009, 8 (02) : 77 - 87
  • [42] Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
    Viola-Villegas, Nerissa Therese
    Sevak, Kuntal K.
    Carlin, Sean D.
    Doran, Michael G.
    Evans, Henry W.
    Bartlett, Derek W.
    Wu, Anna M.
    Lewis, Jason S.
    MOLECULAR PHARMACEUTICS, 2014, 11 (11) : 3965 - 3973
  • [43] PET Molecular Imaging of 89Zr-Labeled Monoclonal Antibodies - Solid Target System and Automatic Purification System for 89Zr-
    Kato, Jun
    Oda, Takashi
    Ueno, Satoshi
    Ishizuka, Toru
    Yano, Tsuneo
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [44] Investigation of 89Zr+4 chelation for positron emission tomography
    Chung, Aaron
    Abdalrahman, Mahmoud
    Barron, Brady
    Planalp, Roy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [45] Novel bifunctional tetrahydroximate chelators for labeling antibodies with Zr-89 for imaging with positron emission tomography
    Rousseau, Julie
    Zhang, Zhengxing
    Wang, Xiaozhu
    Zhang, Chengcheng
    Merkens, Helen
    Colpo, Nadine
    Benard, Francois
    Lin, Kuo-Shyan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [46] PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer
    Meher, Niranjan
    Bidkar, Anil P.
    Wadhwa, Anju
    Bobba, Kondapa Naidu
    Dhrona, Suchi
    Dasari, Chandrashekhar
    Mu, Changhua
    Fong, Cyril O. Y.
    Camara, Juan A.
    Ali, Umama
    Basak, Megha
    Bulkley, David
    Steri, Veronica
    Fontaine, Shaun D.
    Zhu, Jun
    Oskowitz, Adam
    Aggarwal, Rahul R.
    Sriram, Renuka
    Chou, Jonathan
    Wilson, David M.
    Seo, Youngho
    Santi, Daniel V.
    Ashley, Gary W.
    Vanbrocklin, Henry F.
    Flavell, Robert R.
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (01) : 141 - 151
  • [47] 124I-huA33 Antibody PET of Colorectal Cancer
    Carrasquillo, Jorge A.
    Pandit-Taskar, Neeta
    O'Donoghue, Joseph A.
    Humm, John L.
    Zanzonico, Pat
    Smith-Jones, Peter M.
    Divgi, Chaitanya R.
    Pryma, Daniel A.
    Ruan, Shutian
    Kemeny, Nancy E.
    Fong, Yuman
    Wong, Douglas
    Jaggi, Jaspreet S.
    Scheinberg, David A.
    Gonen, Mithat
    Panageas, Katherine S.
    Ritter, Gerd
    Jungbluth, Achim A.
    Old, Lloyd J.
    Larson, Steven M.
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (08) : 1173 - 1180
  • [48] In vitro and in vivo characterization of 89Zr-labeled anti-VISTA antibody CI-8993
    Burvenich, I.
    Wichmann, C. W.
    McDonald, A. F.
    Scott, F. E.
    Guo, N.
    Rigopoulos, A.
    Huynh, N.
    Soikes, Rl
    Angelides, S.
    von Roemeling, M. D. Reinhard
    Scott, A. M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 8 - 8
  • [49] Positron Emission Tomography Imaging of Tumor Angiogenesis with a 66Ga-Labeled Monoclonal Antibody
    Engle, Jonathan W.
    Hong, Hao
    Zhang, Yin
    Valdovinos, Hector F.
    Myklejord, Duane V.
    Barnhart, Todd E.
    Theuer, Charles P.
    Nickles, Robert J.
    Cai, Weibo
    MOLECULAR PHARMACEUTICS, 2012, 9 (05) : 1441 - 1448
  • [50] PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats
    Brouwers, A
    Verel, I
    Van Eerd, J
    Visser, G
    Steffens, M
    Oosterwijk, E
    Corstens, F
    Oyen, W
    Van Dongen, G
    Boerman, O
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (02) : 155 - 163
12345